KardiaMobile 6L can be used to measure QT duration in COVID-19 patients - Cardiac Rhythm News
KardiaMobile 6L, which it describes in a press release as the world’s only six lead personal ECG.
Implementation of a fully remote randomized clinical trial with cardiac monitoring
A comparison of ECG-based home monitoring devices in adults with CHD, Cardiology in the Young
RApid Throughput Screening for Asymptomatic COVID-19 Infection With an Electrocardiogram: A Prospective Observational Study - Mayo Clinic Proceedings: Digital Health
2021 ISHNE/HRS/EHRA/APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals - Varma - 2021 - Journal of Arrhythmia - Wiley Online Library
Figure. Measuring the QT Interval in Different Clinical Scenarios
New FDA guidance allows use of KardiaMobile 6L to measure QTc in COVID-19 patients
Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device
Mayo Clinic research yields breakthrough in mobile determination of QT prolongation - Mayo Clinic News Network
Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device
AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder
How To Measure and Assess a Long QT Interval
2021 ISHNE/HRS/EHRA/APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals - Varma - 2021 - Journal of Arrhythmia - Wiley Online Library
